Pular para o conteúdo
Merck
  • Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis.

Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis.

Molecular carcinogenesis (2014-04-05)
Qiang Dang, Wenbin Song, Defeng Xu, Yanmin Ma, Feng Li, Jin Zeng, Guodong Zhu, Xinyang Wang, Luke S Chang, Dalin He, Lei Li
RESUMO

The effects of the flavonoid compound, kaempferol, which is an inhibitor of cancer cell proliferation and an inducer of cell apoptosis have been shown in various cancers, including lung, pancreatic, and ovarian, but its effect has never been studied in bladder cancer. Here, we investigated the effects of kaempferol on bladder cancer using multiple in vitro cell lines and in vivo mice studies. The MTT assay results on various bladder cancer cell lines showed that kaempferol enhanced bladder cancer cell cytotoxicity. In contrast, when analyzed by the flow cytometric analysis, DNA ladder experiment, and TUNEL assay, kaempferol significantly was shown to induce apoptosis and cell cycle arrest. These in vitro results were confirmed in in vivo mice studies using subcutaneous xenografted mouse models. Consistent with the in vitro results, we found that treating mice with kaempferol significant suppression in tumor growth compared to the control group mice. Tumor tissue staining results showed decreased expressions of the growth related markers, yet increased expressions in apoptosis markers in the kaempferol treated group mice tissues compared to the control group mice. In addition, our in vitro and in vivo data showed kaempferol can also inhibit bladder cancer invasion and metastasis. Further mechanism dissection studies showed that significant down-regulation of the c-Met/p38 signaling pathway is responsible for the kaempferol mediated cell proliferation inhibition. All these findings suggest kaempferol might be an effective and novel chemotherapeutic drug to apply for the future therapeutic agent to combat bladder cancer.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Dodecilsulfato de sódio, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
Dodecilsulfato de sódio, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
N,N-Dimetilacetamida, ReagentPlus®, ≥99%
Sigma-Aldrich
Dodecilsulfato de sódio, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
Dodecilsulfato de sódio, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, ACS reagent, ≥99.0%
Sigma-Aldrich
Kaempferol, ≥97.0% (HPLC)
Supelco
Dodecilsulfato de sódio, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
N,N-Dimetilacetamida, anhydrous, 99.8%
Sigma-Aldrich
Dodecilsulfato de sódio, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, ≥98.0% (GC)
Sigma-Aldrich
Kaempferol, ≥90% (HPLC), powder
Sigma-Aldrich
N,N-Dimetilacetamida, suitable for peptide synthesis, ≥99.8% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
Dodecilsulfato de sódio, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Sigma-Aldrich
Dodecilsulfato de sódio, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
N,N-Dimethylacetamide-d9, 99 atom % D
Sigma-Aldrich
Dodecilsulfato de sódio, ≥90% ((Assay))
SAFC
N,N-Dimetilacetamida, Ph. Eur.
Sigma-Aldrich
5-(N,N-Dimethyl)amiloride hydrochloride
Sigma-Aldrich
Dodecilsulfato de sódio, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC), free-flowing, Redi-Dri